Stanford researchers led by Gill Bejerano have developed an algorithm that can rapidly inform diagnoses using clinical records.
Scientists create algorithms that read X-rays and MRIs in an effort to enhance doctor's diagnoses of certain disease and injury.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
PHIND scientists discuss how to stop disease in its track, aiming for earlier diagnostics and more precise medical treatments.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
A genetic test may predict at an early age those likely to develop osteoporosis. Knowing your risk may allow easy interventions to prevent future fractures.
Scientists at Stanford find a biomarker for flu susceptibility, enabling predictions of if someone is going to fall ill to the virus after being exposed.
A Stanford-led research team has developed a simple blood test for pregnant women that shows, with 75-80 percent accuracy, which pregnancies will end in premature birth.
Scientists who work with the Stanford Precision Health and Integrated Diagnostics Center set out to find new ways to precisely predict, prevent and diagnose diseases that range from diabetes to mental health.
A kidney disease of unknown origin is sickening many men in Sri Lanka. Stanford researcher Shuchi Anand is working to understand it and to improve care.
Vasopressin levels are low in the cerebrospinal fluid of less-social rhesus monkeys and in people with autism, the study found. The discovery suggests that it may be possible to design a lab test to identify autism in kids.
A Stanford chief resident presents a medical mystery to master diagnostician Lawrence Tierney. Will he solve the puzzle?
A new Clinical Genomics Program at Stanford will improve the diagnosis of rare genetic diseases, benefiting patients such as Tessa and Colton Nye.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.